Analyzing Puma Biotechnology


Puma Biotechnology and Qiagen are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. This is a breakdown of recent ratings and price targets for Puma Biotechnology and Qiagen, as reported by MarketBeat.com.



from Biotech News